Patents by Inventor Cari Loder

Cari Loder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of pain
    Patent number: 6989380
    Abstract: A method of treating pain by the co-administration of an antidepressant together with one or more precursors or inducers of neurotransmitters, particularly amino acids selected from L-phenylalanine, L-tyrosine, L-tryptophan and L-DOPA.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: January 24, 2006
    Assignee: The WKK Trust
    Inventors: David Frederick Horrobin, Cari Loder, Graham Cooper
  • Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tyrptophan and possibly a vitamin B12 compound
    Patent number: 6569850
    Abstract: Method for treating multiple sclerosis or encephalomyelitis by administering to a patient a combination of a tricyclic antidepressant drug and tyrosine or phenylalanine or both.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: May 27, 2003
    Inventor: Cari Loder
  • Treatment of pain
    Patent number: 6451788
    Abstract: A method of treating pain by the co-administration of an antidepressant together with one or more precursors or inducers of neurotransmitters, particularly amino acids selected from L-phenylalanine, L-tyrosine, L-tryptophan and L-DOPA.
    Type: Grant
    Filed: January 4, 2000
    Date of Patent: September 17, 2002
    Assignee: The WWK Trust of 225-235 High Street
    Inventors: David Frederick Horrobin, Cari Loder, Graham Cooper
  • Treatment of fatigue, head injury and stroke
    Patent number: 6441038
    Abstract: A method of treatment of disorders of neurological origin and drug formulations for use in the method are disclosed. These conditions comprise fatigue and associated syndromes of pain, weakness and depressed mood which are associated with chronic fatigue syndrome, brain injury and stroke, stress, fibromyalgia, and irritable bowel syndrome. The treatment comprises administering to a patient in need thereof a selective inhibitor of noradrenaline reuptake combined with either phenylalanine or tyrosine in the same dosage form or the same pack.# The noradrenergic drug may be selected from lofepramine, desipramine or reboxetine. The selective inhibitor may be a combined inhibitor of both noradrenaline and serotonin reuptake such as venlafaxine, duloxetine or milnacipran, or an inhibitor of both noradrenaline and dopamine reuptake such as bupropion.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: August 27, 2002
    Assignee: Laxdale Limited
    Inventors: Cari Loder, David F. Horrobin
  • Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tryptophan and possibly a vitamin B12 compound
    Patent number: 6096737
    Abstract: The use of a combination of a tricyclic or tetracyclic antidepressant, a serotonin reuptake inhibitor, or a monoamine oxidase inhibitor with a neurotransmitter-inducing or precursor compound is proposed in the preparation of medication for the treatment or prevention of multiple sclerosis or other demyelinating conditions. For use in treatment to ameliorate the effects of a demyelinating condition, a daily regime is proposed of from 10 to 220 mg lofepramine and from 100 mg to 5 g of L-phenylalanine, optionally supplemented with injections of vitamin B.sub.12.
    Type: Grant
    Filed: June 27, 1997
    Date of Patent: August 1, 2000
    Inventor: Cari Loder